Cortina Asset Management’s Myriad Genetics MYGN Stock Holding History

Cortina Asset Management’s Portfolio MYGN Stock Details MYGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q2	$5.76M	Buy	207,419 +53,173	+34%	+$1.5M	0.36%	115
2019 Q1	$5.12M	Buy	+154,246	New	+$4.7M	0.32%	133
2016 Q3	–	Sell	-182,606	Closed	-$5.59M	–	246
2016 Q2	$5.59M	Sell	182,606 -21,310	-10%	-$740K	0.25%	150
2016 Q1	$7.63M	Sell	203,916 -3,036	-1%	-$114K	0.35%	112
2015 Q4	$8.93M	Buy	206,952 +37,336	+22%	+$1.58M	0.4%	88
2015 Q3	$6.36M	Buy	+169,616	New	+$6.02M	0.29%	135
2013 Q3	–	Sell	-336,784	Closed	-$9.05M	–	257
2013 Q2	$9.05M	Buy	+336,784	New	+$9.76M	0.36%	107

Other funds holding MYGN

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

FCM

Frontier Capital Management Boston, Massachusetts $9.73B AUM 55.65% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

DGI

Disciplined Growth Investors Minneapolis, Minnesota $4.89B AUM 33.85% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Cortina Asset Management's MYGN Position: Q2 2019 in Review

Cortina Asset Management increased its Myriad Genetics (MYGN) stake by 34% in Q2 2019, buying an estimated $1.5M and bringing the position to 207,419 shares worth $5.76M. The position accounts for 0.36% of the portfolio, ranked #115.

Cortina Asset Management first reported a position in MYGN in Q2 2013 and has held it in 7 quarters since. The position peaked at $9.05M in Q2 2013. 235 funds tracked by Wall St. Rank hold MYGN as of Q2 2019.

Cortina Asset Management held 207,419 shares of Myriad Genetics worth $5.76M as of Q2 2019.
Cortina Asset Management bought 53,173 Myriad Genetics shares in Q2 2019, an estimated $1.5M.
Myriad Genetics made up 0.36% of Cortina Asset Management's portfolio in Q2 2019, its #115 holding.
Cortina Asset Management first reported a position in Myriad Genetics in Q2 2013 and has held it in 7 quarters since.
Cortina Asset Management's Myriad Genetics position peaked at $9.05M in Q2 2013.
235 funds tracked by Wall St. Rank held Myriad Genetics as of Q2 2019.

Based on Cortina Asset Management's 13F filing for Q2 2019, filed 2 Jul 2019.